Oh Se-Yang, Lim Yong Cheol, Shim Yu Shik, Song Jihye, Park Sang Kyu, Sim Sook Young, Kim Myeong Jin, Shin Yong Sam, Chung Joonho
Department of Neurosurgery, Inha University College of Medicine, Incheon, Republic of Korea.
Department of Neurosurgery, Ajou University College of Medicine, Suwon, Republic of Korea.
Acta Neurochir (Wien). 2018 Jun;160(6):1105-1113. doi: 10.1007/s00701-018-3552-6. Epub 2018 Apr 20.
Predicting the fate of patients who are given a misdiagnosis of aneurysmal subarachnoid hemorrhage (aSAH) remains unclear. The purpose was to examine factors associated with initial misdiagnosis of aSAH and to investigate the impact of initial misdiagnosis of aSAH on clinical outcomes.
Between January 2007 and December 2015, medical records and radiographic data for 3118 consecutive patients with aSAH were reviewed. There were 33 patients who had been documented with an initial misdiagnosis of aSAH, and all met the following criteria: (1) failure to correctly identify aSAH upon initial presentation to health care professionals; and 2) subsequently documented aSAH after the initial misdiagnosis. After applying exclusion criteria, remaining 2898 patients were included in the control group.
The most common cause of the misdiagnosis is failure to detect aSAH on the initial radiographic imaging. Misdiagnosis group showed lower initial Glasgow Coma Scale, better Hunt-Hess grade, and lower Fisher's grade. Logistic regression analysis showed that initial HH grade (OR, 0.216; p = 0.014), initial Fisher's grade (OR, 0.732; p = 0.036), and hospital type during initial contact (OR, 2.266; p = 0.042) were independently associated with misdiagnosis of aSAH.
Patients with initially good HH grade, lower Fisher's grade, and visiting non-teaching hospital for initial contact were at risk of being misdiagnosed. Misdiagnosis of aSAH in patients with initial good HH grade did affect clinical outcomes negatively. The rebleeding rate was not significantly different between two groups. However, the mortality rate due to rebleeding was higher in MisDx group than in non-MisDx group.
对于被误诊为动脉瘤性蛛网膜下腔出血(aSAH)患者的预后预测仍不明确。本研究旨在探讨与aSAH初始误诊相关的因素,并调查aSAH初始误诊对临床结局的影响。
回顾2007年1月至2015年12月期间3118例连续aSAH患者的病历和影像学资料。有33例患者被记录为初始误诊为aSAH,且均符合以下标准:(1)初次就诊于医护人员时未正确识别aSAH;(2)初始误诊后随后记录为aSAH。应用排除标准后,其余2898例患者纳入对照组。
误诊最常见的原因是初始影像学检查未发现aSAH。误诊组初始格拉斯哥昏迷量表评分较低、Hunt-Hess分级较好、Fisher分级较低。逻辑回归分析显示,初始Hunt-Hess分级(OR,0.216;p = 0.014)、初始Fisher分级(OR,0.732;p = 0.036)和初次就诊时的医院类型(OR,2.266;p = 0.042)与aSAH误诊独立相关。
初始Hunt-Hess分级较好、Fisher分级较低且初次就诊于非教学医院的患者有被误诊的风险。初始Hunt-Hess分级较好的患者aSAH误诊确实对临床结局有负面影响。两组再出血率无显著差异。然而,误诊组因再出血导致的死亡率高于非误诊组。